Following on his previous announcement, Attorney General Ken Paxton announced his intention to join the $21 billion opioid distributor settlement in a press conference on Thursday.
Attorney General Ken Paxton announced a historic $26 billion agreement that will bring desperately needed relief to Texans who are struggling with opioid addiction. The agreement includes Cardinal, McKesson, and AmerisourceBergen – the nation’s three major pharmaceutical distributors – and Johnson & Johnson, which manufactured and marketed opioids.
Purdue Pharma Files Bankruptcy Plan, Establishing Trust for Nationwide Opioid Abatement Efforts
Texas Attorney General Ken Paxton today announced that Purdue Pharma filed its estimated $7 billion bankruptcy plan, which places the value of the company into a trust set up to allocate funds toward opioid abatement efforts across the nation.
AG Paxton: Updated Settlement Reached with Opioid Manufacturer Mallinckrodt Following Company Bankruptcy
Attorney General Ken Paxton today announced an update to a global settlement framework agreement between state attorneys general, local subdivisions, and the opioid manufacturer Mallinckrodt (MNK), its subsidiaries, and other affiliates.
Attorney General Ken Paxton today announced a global settlement framework agreement between state attorneys general, local subdivisions, and Mallinckrodt (MNK), its subsidiaries, and certain other affiliates.
AG Paxton: All U.S. Attorneys General Call on Congress to Pass Bipartisan FIGHT Fentanyl Act
Attorney General Ken Paxton today joined all 56 attorneys general in calling for Congress to pass the bipartisan Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act.
Attorney General Ken Paxton Issues Statement on Chapter 11 Bankruptcy Filing of Purdue Pharma
Attorney General Paxton released the following statement in response to the Chapter 11 bankruptcy filing of Purdue Pharma and all affiliated U.S. companies in the United States Bankruptcy Court for the Southern District of New York.
Texas Attorney General Ken Paxton announced that his office filed a civil Medicaid fraud lawsuit against pharmaceutical manufacturer Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, Inc., for misrepresentations made to the Texas Medicaid program about their dangerous opioid drug, Duragesic.
AG Paxton Joins U.S. AG Sessions at Press Conference Announcing DOJ’s New Steps to Combat the Nation’s Opioid Epidemic
“I shouldn't have to tell another story like this one, nor should anyone else,” Attorney General Paxton said. “The opioid crisis demands the attention of federal, state, local and private sector leaders. My office will continue to do everything it can to protect Texans from the opioid crisis.”